Adrien Panis, Alexandre De La Taille, Bastien Parier, Sarah J Drouin, Marie Matignon, Dany Anglicheau, Catherine Fournier, Arnaud Méjean, Marc-Olivier Timsit
{"title":"牺牲肾副动脉会损害活体肾移植后的功能结局吗?一项包含251名接受者的回顾性单中心队列研究","authors":"Adrien Panis, Alexandre De La Taille, Bastien Parier, Sarah J Drouin, Marie Matignon, Dany Anglicheau, Catherine Fournier, Arnaud Méjean, Marc-Olivier Timsit","doi":"10.1111/ctr.70229","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>The use of kidneys with multiple arteries (MAs) in living donor transplantation expands the donor pool. However, when accessory arteries are of small caliber or recipient iliac atherosclerosis is significant, reimplantation may not be feasible. Our objective was to assess renal consequences of accessory arteries sacrifice.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>This single-center retrospective study included 251 consecutive living donor kidney transplants performed between April 2019 and June 2023. Patients were classified into three groups: single artery (SA), multiple arteries with full preservation (MAP), and multiple arteries without reimplantation (MAWR). Accessory arteries caliber and location, early and late complications, graft survival, renal function, and transplant imaging features were compared between groups.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>Comparing MAWR (<i>N</i> = 23) and MAP (<i>N</i> = 45), accessory renal arteries were more sacrificed when supplying upper pole (63% vs. 15%), mean main artery diameter was larger (5.65 mm vs. 4.78 mm, <i>p</i> < 0.01), and mean accessory artery diameter was smaller (1.91 mm vs. 3.11 mm, <i>p</i> < 0.01). No difference in early or late complication or allotransplant survival was observed among SA (<i>n</i> = 183), MAP, or MAWR. We found no significant difference in renal function at 7 days (<i>p</i> = 0.96), 6 months (<i>p</i> = 0.72), or 12 months (<i>p</i> = 0.24) post transplantation as compared with SA or MAP, despite presence of limited perfusion defect on ultrasound in MAWR recipients.</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>In selected cases, sacrifice of accessory renal arteries not amenable to reimplantation in living donor kidney transplantation was not associated with renal transplant impairment or any clinical negative outcome. Our study also emphasizes that kidneys with MAs should not be excluded from living donation.</p>\n </section>\n </div>","PeriodicalId":10467,"journal":{"name":"Clinical Transplantation","volume":"39 7","pages":""},"PeriodicalIF":1.9000,"publicationDate":"2025-07-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/ctr.70229","citationCount":"0","resultStr":"{\"title\":\"Does the Sacrifice of Accessory Renal Arteries Impair Functional Outcomes After Living Donor Kidney Transplantation? A Retrospective Single-Center Cohort Study of 251 Recipients\",\"authors\":\"Adrien Panis, Alexandre De La Taille, Bastien Parier, Sarah J Drouin, Marie Matignon, Dany Anglicheau, Catherine Fournier, Arnaud Méjean, Marc-Olivier Timsit\",\"doi\":\"10.1111/ctr.70229\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div>\\n \\n \\n <section>\\n \\n <h3> Background</h3>\\n \\n <p>The use of kidneys with multiple arteries (MAs) in living donor transplantation expands the donor pool. However, when accessory arteries are of small caliber or recipient iliac atherosclerosis is significant, reimplantation may not be feasible. Our objective was to assess renal consequences of accessory arteries sacrifice.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Methods</h3>\\n \\n <p>This single-center retrospective study included 251 consecutive living donor kidney transplants performed between April 2019 and June 2023. Patients were classified into three groups: single artery (SA), multiple arteries with full preservation (MAP), and multiple arteries without reimplantation (MAWR). Accessory arteries caliber and location, early and late complications, graft survival, renal function, and transplant imaging features were compared between groups.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Results</h3>\\n \\n <p>Comparing MAWR (<i>N</i> = 23) and MAP (<i>N</i> = 45), accessory renal arteries were more sacrificed when supplying upper pole (63% vs. 15%), mean main artery diameter was larger (5.65 mm vs. 4.78 mm, <i>p</i> < 0.01), and mean accessory artery diameter was smaller (1.91 mm vs. 3.11 mm, <i>p</i> < 0.01). No difference in early or late complication or allotransplant survival was observed among SA (<i>n</i> = 183), MAP, or MAWR. We found no significant difference in renal function at 7 days (<i>p</i> = 0.96), 6 months (<i>p</i> = 0.72), or 12 months (<i>p</i> = 0.24) post transplantation as compared with SA or MAP, despite presence of limited perfusion defect on ultrasound in MAWR recipients.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Conclusion</h3>\\n \\n <p>In selected cases, sacrifice of accessory renal arteries not amenable to reimplantation in living donor kidney transplantation was not associated with renal transplant impairment or any clinical negative outcome. Our study also emphasizes that kidneys with MAs should not be excluded from living donation.</p>\\n </section>\\n </div>\",\"PeriodicalId\":10467,\"journal\":{\"name\":\"Clinical Transplantation\",\"volume\":\"39 7\",\"pages\":\"\"},\"PeriodicalIF\":1.9000,\"publicationDate\":\"2025-07-10\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1111/ctr.70229\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical Transplantation\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1111/ctr.70229\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"SURGERY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Transplantation","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/ctr.70229","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0
摘要
多动脉肾在活体供体移植中的应用扩大了供体池。然而,当副动脉小口径或受体髂动脉粥样硬化明显时,再植可能不可行。我们的目的是评估副动脉牺牲对肾脏的影响。方法本研究为单中心回顾性研究,纳入2019年4月至2023年6月间251例连续活体肾移植手术。患者分为三组:单动脉组(SA)、多动脉完整保存组(MAP)和多动脉不移植组(MAWR)。比较两组副动脉直径及位置、早期和晚期并发症、移植物存活率、肾功能及移植物影像学特征。结果对比MAWR (N = 23)和MAP (N = 45),供血上极时副肾动脉牺牲较多(63% vs. 15%),平均大动脉直径较大(5.65 mm vs. 4.78 mm, p <;0.01),平均副动脉直径较小(1.91 mm vs. 3.11 mm, p <;0.01)。SA (n = 183)、MAP和MAWR在早期或晚期并发症或同种异体移植存活率方面没有差异。尽管超声显示MAWR受者存在有限的灌注缺陷,但与SA或MAP相比,移植后7天(p = 0.96)、6个月(p = 0.72)或12个月(p = 0.24)肾功能无显著差异。结论在部分病例中,在活体肾移植中牺牲不适合再植的副肾动脉与肾移植损害或任何临床阴性结果无关。我们的研究还强调,不应排除有MAs的肾脏进行活体捐赠。
Does the Sacrifice of Accessory Renal Arteries Impair Functional Outcomes After Living Donor Kidney Transplantation? A Retrospective Single-Center Cohort Study of 251 Recipients
Background
The use of kidneys with multiple arteries (MAs) in living donor transplantation expands the donor pool. However, when accessory arteries are of small caliber or recipient iliac atherosclerosis is significant, reimplantation may not be feasible. Our objective was to assess renal consequences of accessory arteries sacrifice.
Methods
This single-center retrospective study included 251 consecutive living donor kidney transplants performed between April 2019 and June 2023. Patients were classified into three groups: single artery (SA), multiple arteries with full preservation (MAP), and multiple arteries without reimplantation (MAWR). Accessory arteries caliber and location, early and late complications, graft survival, renal function, and transplant imaging features were compared between groups.
Results
Comparing MAWR (N = 23) and MAP (N = 45), accessory renal arteries were more sacrificed when supplying upper pole (63% vs. 15%), mean main artery diameter was larger (5.65 mm vs. 4.78 mm, p < 0.01), and mean accessory artery diameter was smaller (1.91 mm vs. 3.11 mm, p < 0.01). No difference in early or late complication or allotransplant survival was observed among SA (n = 183), MAP, or MAWR. We found no significant difference in renal function at 7 days (p = 0.96), 6 months (p = 0.72), or 12 months (p = 0.24) post transplantation as compared with SA or MAP, despite presence of limited perfusion defect on ultrasound in MAWR recipients.
Conclusion
In selected cases, sacrifice of accessory renal arteries not amenable to reimplantation in living donor kidney transplantation was not associated with renal transplant impairment or any clinical negative outcome. Our study also emphasizes that kidneys with MAs should not be excluded from living donation.
期刊介绍:
Clinical Transplantation: The Journal of Clinical and Translational Research aims to serve as a channel of rapid communication for all those involved in the care of patients who require, or have had, organ or tissue transplants, including: kidney, intestine, liver, pancreas, islets, heart, heart valves, lung, bone marrow, cornea, skin, bone, and cartilage, viable or stored.
Published monthly, Clinical Transplantation’s scope is focused on the complete spectrum of present transplant therapies, as well as also those that are experimental or may become possible in future. Topics include:
Immunology and immunosuppression;
Patient preparation;
Social, ethical, and psychological issues;
Complications, short- and long-term results;
Artificial organs;
Donation and preservation of organ and tissue;
Translational studies;
Advances in tissue typing;
Updates on transplant pathology;.
Clinical and translational studies are particularly welcome, as well as focused reviews. Full-length papers and short communications are invited. Clinical reviews are encouraged, as well as seminal papers in basic science which might lead to immediate clinical application. Prominence is regularly given to the results of cooperative surveys conducted by the organ and tissue transplant registries.
Clinical Transplantation: The Journal of Clinical and Translational Research is essential reading for clinicians and researchers in the diverse field of transplantation: surgeons; clinical immunologists; cryobiologists; hematologists; gastroenterologists; hepatologists; pulmonologists; nephrologists; cardiologists; and endocrinologists. It will also be of interest to sociologists, psychologists, research workers, and to all health professionals whose combined efforts will improve the prognosis of transplant recipients.